| Across |
| 3. | Nicotinic acid commonly causes this adverse reaction |
| 4. | These medications cause the greatest lowering of LDL |
| 6. | Mevacor is a member of this class of medications |
| 7. | Lowest dosed tablet available of Zocor |
| 8. | Vytorin is a combination of simvastatin and this medication |
| 11. | The number of weeks between monitoring for patients initially |
| 12. | Main monitoring tool for lipids. |
| 14. | Choestyramine is considered a bile acid ____ |
| 16. | Statins inhibit this enzyme |
| 17. | Ideally, should be <200mg/dl for an average person |
| 19. | Nicotinic acid ER |
| 21. | Gemfibrozil brand name |
| 22. | Reduction in CHD rates and increase in HDL is possible with light use of this |
| 26. | These are produced by macrophages |
| 27. | Ideally, should be <100mg/dl for an average person |
| 28. | If a fasting lipid panel is normal, screening is repeated after ____ years. |
| 29. | Adverse effect to monitor for with statins |
| 33. | Refers to any lipid disorder |
| 34. | These types of fats are welcomed with dyslipidemia |
| 36. | Elevation in blood concentration of a lipid such as cholesterol or triglyceride. |
| 43. | Cholesterol Inhibitor |
| 44. | Majority of diet for maintaining normal cholesterol should come from this |
| 46. | Diabetics could potentially experience this with niacin |
| 47. | Lipid disorders are classified as |
| 50. | Elderly patients may experience this adverse effect when taking a bile acid sequestrant |
| 51. | This supplement can reduce TGs up to 30-60% |
| 52. | This type of fiber is good for lowering LDL |
| 53. | Brand name of Rosuvastatin |
| 54. | Brand name of Colesevelam |
| 55. | An HDL > or = to this number counts as a negative risk factor. |
| 56. | Major non lipid risk factor for CHD |